1. Home
  2. CCC vs BLTE Comparison

CCC vs BLTE Comparison

Compare CCC & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CCC Intelligent Solutions Holdings Inc.

CCC

CCC Intelligent Solutions Holdings Inc.

N/A

Current Price

$5.57

Market Cap

4.8B

Sector

Technology

ML Signal

N/A

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$182.36

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCC
BLTE
Founded
1980
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.1B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
CCC
BLTE
Price
$5.57
$182.36
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$10.38
$161.57
AVG Volume (30 Days)
13.2M
241.4K
Earning Date
02-24-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,025,600,000.00
N/A
Revenue This Year
$12.72
N/A
Revenue Next Year
$9.11
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10.64
N/A
52 Week Low
$5.57
$49.00
52 Week High
$11.23
$200.00

Technical Indicators

Market Signals
Indicator
CCC
BLTE
Relative Strength Index (RSI) 18.15 63.06
Support Level $5.57 $175.18
Resistance Level $7.64 $192.94
Average True Range (ATR) 0.36 11.25
MACD -0.26 1.50
Stochastic Oscillator 7.40 59.96

Price Performance

Historical Comparison
CCC
BLTE

About CCC CCC Intelligent Solutions Holdings Inc.

CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, and AI-enabled digital workflows. It operates in a single segment being Domestic segment which provides SAAS platform for the P&C insurance economy and derives revenues from providing customers with software subscriptions to the platform in addition to providing professional services and non-software services. The company has its presence in United States and China. Majority of the revenue is generated from United States.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: